Article Information
History
- October 2, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Laura Ochoa-Callejero1,
- Josune García-Sanmartín1,
- Pablo Villoslada-Blanco2,
- María Íñiguez2,
- Patricia Pérez-Matute2,
- Rachel Brody3,
- José A. Oteo2,4 and
- Alfredo Martínez1,*
- 1Oncology Area, Center for Biomedical Research of La Rioja (CIBIR), Logroño, Spain
- 2Infectious Diseases, Microbiota, and Metabolism Unit (CIBIR), Logroño, Spain
- 3Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, USA
- 4Infectious Diseases Department. Hospital Universitario San Pedro, Logroño, Spain
- ↵*Correspondence to: Alfredo Martínez, Angiogenesis Group, Oncology Area, Center for Biomedical Research of La Rioja (CIBIR), Piqueras 98, 26006 Logroño, Spain. Phone: +34 941278775; Fax: +34 941278887; email: amartinezr{at}riojasalud.es
Posted October 02, 2020.
Circulating levels of calcitonin gene-related peptide (CGRP) are lower in COVID-19 patients
